Understanding sleep problems in children with rare genetic syndromes
Elucidating the causes and consequences of sleep disturbances in children with rare genetic syndromes
This study is looking into how sleep problems affect kids with rare genetic syndromes like Prader-Willi syndrome, so we can find better ways to help them sleep well and improve their overall health and happiness.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10693335 on NIH RePORTER |
What this research studies
This research investigates the causes and effects of sleep disturbances in children with rare genetic syndromes, particularly focusing on Prader-Willi syndrome. By analyzing data from electronic health records, the study aims to identify how sleep issues impact neurodevelopment and overall health. The goal is to develop effective treatment strategies that can improve sleep quality and, consequently, the quality of life for these children and their families. The research highlights the importance of addressing sleep as a modifiable risk factor in managing these complex conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years diagnosed with rare genetic syndromes, particularly those with Prader-Willi syndrome.
Not a fit: Patients without genetic syndromes or those outside the specified age range may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved sleep management strategies that enhance the health and quality of life for children with rare genetic syndromes.
How similar studies have performed: Previous research has shown that addressing sleep disturbances can significantly improve health outcomes in children with neurodevelopmental disorders, suggesting a promising avenue for this study.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Veatch, Olivia J — University of Kansas Medical Center
- Study coordinator: Veatch, Olivia J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.